|
Dr. Medve earned his doctorate of medicine at Jefferson Medical College in Philadelphia, Pennsylvania, and he completed his residency in the anesthesia department at Thomas Jefferson University Hospital. Dr. Medve has also completed a pain management fellowship at Roswell Park Cancer Institute in Buffalo New York and served on the staff at the Children�s Hospital of Buffalo.Dr. Medve has held senior positions at Metaphore Pharmaceuticals, Johnson & Johnson and Knoll Pharmaceutical Company. He has experience in the planning and implementation of pre-clinical and clinical development programs, directing formulation development process, and serving as FDA liaison; he has also developed and managed post-marketing programs, negotiated product labeling, and developed promotional materials.Dr. Medve has significant experience with regulatory issues related to pharmaceutical development in the US and Europe. He has filed numerous INDs, SNDAs and NDAs for new molecules, line extensions, combination products, modified-release formulations, and additional indications. He has met with FDA advisory boards and has a long history of cooperative and collegial relationships with the FDA. He has frequently served as a primary spokesperson for sponsors at FDA meetings.Dr. Medve is also a pioneer and recognized expert in pediatric drug development.Dr. Medve will be responsible for consulting with Lifetree Clinical Research� biopharmaceutical partners as they begin to map out their drug development plans for new pain medications. His over ten years� hands-on experience in the development of analgesic drugs, many of which are now on the market worldwide, will be an asset to Lifetree�s clients in all stages of development. | 